{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:48Z","timestamp":1791919608406,"version":"4.3.4"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/cmr.0b013e328333bbe4","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T08:17:40Z","timestamp":1262679460000},"page":"21-34","source":"Crossref","is-referenced-by-count":74,"title":["Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro"],"prefix":"10.1097","volume":"20","author":[{"given":"Karolina","family":"Lesiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Koprowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Zalesna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Nejc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"D\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Czyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","article-title":"Melanoma biology and new targeted therapy","volume":"445","author":"Gray-Schopfer","year":"2007","journal-title":"Nature"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2006.06.0442","article-title":"Toward a molecular classification of melanoma","volume":"25","author":"Fecher","year":"2007","journal-title":"J Clin Oncol"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.1074\/jbc.M112210200","article-title":"A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells","volume":"277","author":"Dhawan","year":"2002","journal-title":"J Biol Chem"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0749.2006.00304.x","article-title":"NF-kappa B activation in melanoma","volume":"19","author":"Ueda","year":"2006","journal-title":"Pigment Cell Res"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1172\/JCI30102","article-title":"Overexpression of Akt converts radial growth melanoma to vertical growth melanoma","volume":"117","author":"Govindarajan","year":"2007","journal-title":"J Clin Invest"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1158\/0008-5472.CAN-05-3589","article-title":"Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase\/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","article-title":"Braf(V600E) cooperates with Pten loss to induce metastatic melanoma","volume":"41","author":"Dankort","year":"2009","journal-title":"Nat Genet"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1535-7163.MCT-06-0084","article-title":"Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases","volume":"5","author":"Smalley","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-04-0731","article-title":"Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas","volume":"64","author":"Hoek","year":"2004","journal-title":"Cancer Res"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1172\/JCI25001","article-title":"Activation of Notch1 signaling is required for \u03b2-catenin-mediated human primary melanoma progression","volume":"115","author":"Balint","year":"2005","journal-title":"J Clin Invest"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/mt.2008.266","article-title":"Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth","volume":"17","author":"Liu","year":"2009","journal-title":"Mol Ther"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4161\/cbt.7.7.6535","article-title":"Transcriptional control of the melanoma malignant phenotype","volume":"7","author":"Melnikova","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/CMR.0b013e32830ce7d7","article-title":"STAT5 contributes to antiapoptosis in melanoma","volume":"18","author":"Hassel","year":"2008","journal-title":"Melanoma Res"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00008390-200508000-00012","article-title":"Snail-regulated genes in malignant melanoma","volume":"15","author":"Kuphal","year":"2005","journal-title":"Melanoma Res"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/cyto.a.10057","article-title":"NF-\u03baB inhibitor sespuiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures","volume":"54A","author":"Pozarowski","year":"2003","journal-title":"Cytometry"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"38954","DOI":"10.1074\/jbc.M203842200","article-title":"Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide","volume":"277","author":"Wen","year":"2002","journal-title":"J Biol Chem"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","article-title":"The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells","volume":"105","author":"Guzman","year":"2005","journal-title":"Blood"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1254\/jphs.SC0060164","article-title":"Parthenolide induces apoptosis in glioblastomas without affecting NF-kappa B","volume":"106","author":"Anderson","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s10495-006-0287-2","article-title":"Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity","volume":"11","author":"Wang","year":"2006","journal-title":"Apoptosis"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.canlet.2003.11.028","article-title":"Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells","volume":"208","author":"Zhang","year":"2004","journal-title":"Cancer Lett"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.leu.2404230","article-title":"The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro","volume":"20","author":"Steele","year":"2006","journal-title":"Leukemia"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2007.03.002","article-title":"Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells","volume":"254","author":"Zunino","year":"2007","journal-title":"Cancer Lett"},{"key":"R23-3-20210129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1074-5521(01)00049-7","article-title":"The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits I kappa B kinase","volume":"8","author":"Kwok","year":"2001","journal-title":"Chem Biol"},{"key":"R24-3-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1667\/RR1128.1","article-title":"Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappa B and split-dose repair","volume":"168","author":"Mendonca","year":"2007","journal-title":"Radiat Res"},{"key":"R25-3-20210129","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1074\/jbc.273.3.1288","article-title":"Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta","volume":"273","author":"Hehner","year":"1998","journal-title":"J Biol Chem"},{"key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1535-7163.MCT-08-0661","article-title":"Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions","volume":"8","author":"Gopal","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"R27-3-20210129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/jpet.108.147934","article-title":"Modulation of DNA methylation by a sesquiterpene lactone Parthenolide","volume":"329","author":"Liu","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"R28-3-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0002-9440(10)64174-0","article-title":"Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase","volume":"161","author":"Straume","year":"2002","journal-title":"Am J Pathol"},{"key":"R29-3-20210129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.jid.5700073","article-title":"Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma","volume":"126","author":"Marini","year":"2006","journal-title":"J Invest Dermatol"},{"key":"R30-3-20210129","first-page":"7642","article-title":"HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma","volume":"61","author":"Polsky","year":"2001","journal-title":"Cancer Res"},{"key":"R31-3-20210129","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1182\/blood-2007-05-090621","article-title":"An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells","volume":"110","author":"Guzman","year":"2007","journal-title":"Blood"},{"key":"R32-3-20210129","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/pros.20931","article-title":"Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: an integrated molecular profiling approach","volume":"69","author":"Kawasaki","year":"2009","journal-title":"Prostate"},{"key":"R33-3-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-007-9798-y","article-title":"NF-kappa B pathway inhibitors preferentially inhibit breast cancer stem-like cells","volume":"111","author":"Zhou","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R34-3-20210129","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","article-title":"A tumorigenic subpopulation with stem cell properties in melanomas","volume":"65","author":"Fang","year":"2005","journal-title":"Cancer Res"},{"key":"R35-3-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.jid.5700017","article-title":"Melanoma, a tumor based on a mutant stem cell?","volume":"126","author":"Grichnik","year":"2006","journal-title":"J Invest Derm"},{"key":"R36-3-20210129","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1158\/0008-5472.CAN-06-1748","article-title":"A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species","volume":"66","author":"Verhaegen","year":"2006","journal-title":"Cancer Res"},{"key":"R37-3-20210129","first-page":"733","article-title":"Cytotoxic effects of a combination of three natural compounds to leukemia cells in vitro","volume":"6","author":"D\u00fcchler","year":"2008","journal-title":"Cancer Ther"},{"key":"R38-3-20210129","first-page":"233","article-title":"Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells","volume":"59","author":"Parada-Turska","year":"2007","journal-title":"Pharmacol Rep"},{"key":"R39-3-20210129","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/ijc.22570","article-title":"Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappa B","volume":"120","author":"Oka","year":"2007","journal-title":"Int J Cancer"},{"key":"R40-3-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jmf.2006.9.55","article-title":"Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines","volume":"9","author":"Wu","year":"2006","journal-title":"J Med Food"},{"key":"R41-3-20210129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(88)92289-1","article-title":"Randomised double-blind placebo-controlled trial of feverfew in migraine prevention","volume":"2","author":"Murphy","year":"1988","journal-title":"Lancet"},{"key":"R42-3-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:DRUG.0000026256.38560.be","article-title":"Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer","volume":"22","author":"Curry","year":"2004","journal-title":"Invest New Drugs"},{"key":"R43-3-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/1078-0432.CCR-06-1559","article-title":"Parthenolide, a natural inhibitor of nuclear factor-kappa B, inhibits lung colonization of murine osteosarcoma cells","volume":"13","author":"Kishida","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R44-3-20210129","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1038\/sj.onc.1207995","article-title":"Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase","volume":"23","author":"Nakshatri","year":"2004","journal-title":"Oncogene"},{"key":"R45-3-20210129","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.jinorgbio.2008.07.014","article-title":"Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines","volume":"102","author":"Michard","year":"2008","journal-title":"J Inorg Biochem"},{"key":"R46-3-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/CMR.0b013e3282f1d312","article-title":"Reactive oxygen species in melanoma and its therapeutic implications","volume":"17","author":"Wittgen","year":"2007","journal-title":"Melanoma Res"},{"key":"R47-3-20210129","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0891-5849(01)00650-5","article-title":"Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes","volume":"31","author":"Meyskens","year":"2001","journal-title":"Free Rad Biol Med"},{"key":"R48-3-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1600-0749.2001.140303.x","article-title":"Redox regulation in human melanocytes and melanoma","volume":"14","author":"Meyskens","year":"2001","journal-title":"Pigment Cell Res"},{"key":"R49-3-20210129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0954-6111(98)90506-6","article-title":"Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy","volume":"92","author":"Gillissen","year":"1998","journal-title":"Respir Med"},{"key":"R50-3-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1568011053765976","article-title":"Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms","volume":"5","author":"Zhang","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"R51-3-20210129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.freeradbiomed.2008.10.025","article-title":"The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth","volume":"46","author":"Cabello","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"R52-3-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bcp.2007.08.024","article-title":"Induction of G2\/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines","volume":"75","author":"Rozenblat","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"R53-3-20210129","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1073\/pnas.0510962103","article-title":"Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress","volume":"103","author":"Wang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R54-3-20210129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/1535-7163.MCT-08-0749","article-title":"Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy","volume":"8","author":"Yang","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"R55-3-20210129","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/jnci\/djn174","article-title":"KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment","volume":"100","author":"Sch\u00f6n","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R56-3-20210129","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1200\/JCO.2005.03.4074","article-title":"Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation","volume":"24","author":"Reu","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008390-201002000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:47:11Z","timestamp":1618033631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201002000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e328333bbe4","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}